Capital Performance Advisors’s Arvinas ARVN Stock Holding History

Capital Performance Advisors’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$148	–	358
2024 Q3	$148	Buy	+6	New	+$157	﹤0.01%	2623

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Performance Advisors's ARVN Position: Q4 2024 in Review

Capital Performance Advisors sold out of Arvinas (ARVN) in Q4 2024, closing a stake of 6 shares — an estimated $148 sold.

Capital Performance Advisors first reported a position in ARVN in Q3 2024 and held it in 1 quarter. The position peaked at $148 in Q3 2024. 198 funds tracked by Wall St. Rank hold ARVN as of Q4 2024.

Capital Performance Advisors reported no remaining Arvinas position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 6 Arvinas shares in Q4 2024, an estimated $148.
Capital Performance Advisors first reported a position in Arvinas in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Arvinas position peaked at $148 in Q3 2024.
198 funds tracked by Wall St. Rank held Arvinas as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.